Retatrutide, developed by Soma Pharmaceuticals , is attracting increasing attention as a potential method for weight management . This dual-action drug combines the mechanism of a GLP-1 receptor stimulant and a GIP receptor activator , aiming to simply promote metabolic improvements but also targ